Cargando…
INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol
BACKGROUND: The course of Alzheimer’s disease (AD) includes a 10–20-year preclinical period with progressive accumulation of amyloid β (Aβ) plaques and neurofibrillary tangles in the absence of symptomatic cognitive or functional decline. The duration of this preclinical stage in part depends on the...
Autores principales: | Moga, Daniela C., Beech, Brooke F., Abner, Erin L., Schmitt, Frederick A., El Khouli, Riham H., Martinez, Ashley I., Eckmann, Lynne, Huffmyer, Mark, George, Rosmy, Jicha, Gregory A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937673/ https://www.ncbi.nlm.nih.gov/pubmed/31888732 http://dx.doi.org/10.1186/s13063-019-3993-0 |
Ejemplares similares
-
Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer’s Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression
por: Moga, Daniela C., et al.
Publicado: (2022) -
Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study
por: Smith, Noah I., et al.
Publicado: (2023) -
One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults
por: Martinez, Ashley I., et al.
Publicado: (2020) -
Optimizing medication appropriateness in older adults: a randomized clinical interventional trial to decrease anticholinergic burden
por: Moga, Daniela C., et al.
Publicado: (2017) -
Amyloid-PET and White Matter Hyperintensities Have Independent Effects on Baseline Cognitive Function and Synergistic Effects on Longitudinal Executive Function
por: Ali, Doaa G., et al.
Publicado: (2023)